Introduction
============

Frailty has emerged as a key medical syndrome that increases the risk of mortality, disability, hospitalization, falls and fractures.[@b1-cia-12-1151] It is now recognized as an essential factor for clinical decision making.[@b2-cia-12-1151] However, clinical criteria and operational definitions of frailty are still the subject of intense study and debate.[@b3-cia-12-1151],[@b4-cia-12-1151] Physical frailty phenotype is the most frequently used frailty instrument,[@b4-cia-12-1151] originally proposed by the criteria of Fried et al.[@b5-cia-12-1151] Despite being described for community-dwelling populations, the Fried frailty criteria proved useful for geriatric inpatient assessment.[@b6-cia-12-1151] Physical frailty phenotype criteria include unintentional weight loss, weakness (assessment based on the hand grip strength measurement), exhaustion, slow gait and low physical activity.[@b5-cia-12-1151] Of these five components, grip strength deserves attention as a simple and objective measure of the frailty syndrome.[@b7-cia-12-1151],[@b8-cia-12-1151] Reduced muscle strength, as measured by grip strength, has been associated with an increased risk of all-cause and cardiovascular mortality; therefore, grip strength is considered a simple, quick and inexpensive means of stratifying an individual's risk of cardiovascular death.[@b9-cia-12-1151] Weak hand grip strength in later life is a risk factor for disability, morbidity and mortality and is central to the definitions of sarcopenia and frailty.[@b10-cia-12-1151],[@b11-cia-12-1151] The measurement of hand grip strength may be especially useful in the context of multimorbidity to identify patients at high risk of adverse outcomes, who may benefit from closer clinical attention.[@b12-cia-12-1151] It proved valuable as a screening tool for frailty in older patients with hematologic malignancies[@b13-cia-12-1151] and predictive of 12-month mortality in patients after transcatheter aortic valve implantation.[@b14-cia-12-1151] Factors associated with muscle strength in a cohort of geriatric ward inpatients have not been extensively studied. The aim of the study was to assess the determinants of grip strength in geriatric inpatients.

Patients and methods
====================

Patients
--------

The study group consisted of 80 consecutive patients aged 78.6±7.0 years ($\overline{X}\  \pm \ \text{SD}$; in the range of 60--92 years), with 68.8% women, admitted to the Department of Geriatrics at University Hospital, No 7 SUM, Uppersilesian Medical Center in Katowice, Poland between October 2014 and December 2014, who provided informed consent for participation in the study. Exclusion criteria included patients unable to provide informed consent because of cognitive impairment.

Measurements
------------

Comprehensive geriatric assessment (CGA) complemented with tests for frailty and body mass assessment was performed for all patients. CGA included a structured interview, physical examination, geriatric functional assessment, blood sampling, electrocardiogram, abdominal ultrasound and chest X-ray. Barthel Index of Activities of Daily Living (Barthel Index)[@b15-cia-12-1151] and Instrumental Activities of Daily Living Scale (IADL)[@b16-cia-12-1151] were used to determine functional status. Mini-Mental State Examination (MMSE)[@b17-cia-12-1151] was used to assess global cognitive performance. Geriatric Depression Scale-Short Form (GDS-SF) was used to screen for depression.[@b18-cia-12-1151] Barthel Index scores range from 0 to 100, IADL from 9 to 27 and MMSE from 0 to 30; higher scores indicate better functional status. GDS-SF scores range from 0 to 15, with higher scores indicating higher depression probability. Modified Get-up and Go Test (scored from 0 to 10, with lower values suggesting increased ambulatory disability) was used to evaluate patient fall risk.[@b19-cia-12-1151],[@b20-cia-12-1151] Frailty was diagnosed according to the criteria of Fried et al.[@b5-cia-12-1151] A Kern digital dynamometer was used for grip strength measurement. Low physical activity (weekly energy expenditure) was calculated on the basis of the modified "Minnesota Leisure Time Activity Questionnaire".[@b21-cia-12-1151],[@b22-cia-12-1151] A Polish language version of the "Frailty Assessment Components: Standardized Protocols" was used. Dementia was diagnosed according to the recommendations of the National Institute on Aging--Alzheimer's Association.[@b23-cia-12-1151] Pain intensity was assessed with the Visual Analog Scale (VAS)[@b24-cia-12-1151],[@b25-cia-12-1151] scored from 0 to 10. Body mass index was calculated for all subjects. Patient survival 2 years after hospital discharge was assessed by making phone calls to patient caregivers.

Statistical analysis
--------------------

Data were analyzed using STATISTICA version 12 (Stat Soft Polska; Stat Soft, Inc., Tulsa, OK, USA). Chi-square test, V-square test and Fisher's exact test were used for categorical variables and the nonparametric Mann--Whitney *U* test for quantitative variables to compare patients with frailty to those without frailty and to compare grip strength in subgroups of patients with various clinical and functional characteristics. The nonparametric Spearman's rank correlation coefficient was used to assess relationships between clinical, functional and laboratory measures and grip strength. Multivariate linear regression was used to assess measures associated with grip strength. Analysis with backward elimination included variables that yielded *P*-values of 0.1 or lower in the initial univariate analysis. To adjust for sex, male grip strength values were multiplied by a factor of (1--SP^2^), where SP denotes a semipartial correlation coefficient for female sex in the multivariate linear regression analysis ([Table 1](#t1-cia-12-1151){ref-type="table"}). The squared semipartial correlation coefficient determines the specific portion of variance explained by a given independent variable in a multivariate linear regression analysis. Multivariate binary logistic regression was performed to assess the association between quantitative and qualitative physical frailty measures and 2-year mortality. The variables were adjusted for age and sex. Multivariate analysis with backward elimination included variables that yielded *P*-values of ≤0.1 in the initial univariate analysis. *P*-values \<0.05 were considered statistically significant.

Ethics
------

The study protocol was approved by the Bioethical Committee of the Medical University of Silesia in Katowice, Poland (Letter KNW/0022/KB1/1/14).

Results
=======

Thirty-two patients (40%) fulfilled the frailty criteria. Thirty patients (37.5%) were classified as prefrail and 18 (22.5%) as nonfrail. As compared to patients without frailty, patients with frailty used more medications, had lower MMSE, Barthel Index, IADL scores and Modified Get-Up and Go Test results; higher GDS scores; lower values of red blood cells (RBCs) and lymphocytes; and lower concentrations of hemoglobin, albumin, total cholesterol and high-density lipoprotein-cholesterol ([Table 2](#t2-cia-12-1151){ref-type="table"}). The frailty weakness criterion (assessed using hand grip strength measurement) was fulfilled in 56 subjects (70%). Grip strength correlated positively with IADL, MMSE, Barthel Index, growth, body mass, hemoglobin concentration, hematocrit, RBC and lymphocyte count, and the concentration of sodium and bilirubin, while it correlated negatively with the number of used medications, GDS, VAS and C-reactive protein (CRP) concentration ([Table 3](#t3-cia-12-1151){ref-type="table"}). MMSE and statin use were independent measures positively associated with grip strength, while female sex, CRP, prior myocardial infarction and use of antidepressants were inversely associated with grip strength in the multivariate linear regression model adjusted for demographic and clinical characteristics, and these factors accounted for 68.6% of the grip strength variance in the study group ([Tables 1](#t1-cia-12-1151){ref-type="table"} and [4](#t4-cia-12-1151){ref-type="table"}). Ten patients (12.5%) died within 2 years of hospital discharge. Low physical activity was the only independent qualitative frailty component (odds ratio =6.000; 95% CI =1.357--26.536; *P*=0.018) and physical activity level was the only quantitative frailty measure (odds ratio =0.998; 95% CI =0.997--1.000; *P*=0.016) associated with 2-year mortality in multivariate logistic regression analysis after adjustment for age and sex.

Discussion
==========

Our observations confirm the multidimensional scope of frailty -- a syndrome that includes both physical and cognitive conditions.[@b26-cia-12-1151] Frailty diagnosed on the basis of physical phenotype criteria was associated with worse MMSE and GDS scores ([Table 2](#t2-cia-12-1151){ref-type="table"}). More advanced functional deterioration in this group is confirmed by the work of other authors indicating that frailty is a major risk factor for disability.[@b1-cia-12-1151] In addition to lower hemoglobin, albumin and vitamin D levels, as compared to subjects without frailty, patients with frailty had lower total cholesterol and high-density lipoprotein-cholesterol. While attention toward the treatment of hypercholesterolemia is emphasized in many guidelines, low total cholesterol may be a marker of health deterioration. Grip strength, a component of the five physical frailty criteria,[@b5-cia-12-1151] is also considered a biomarker of aging and a predictor of disability, morbidity and mortality.[@b27-cia-12-1151] Grip strength was a better predictor of all-cause and cardiovascular mortality than systolic blood pressure in more than 140,000 participants aged 35--70 years from the PURE Study.[@b9-cia-12-1151] In primary care outpatients aged 60 years or more, without IADL impairment, grip strength was associated with age, female sex, height, depression and mobility problems.[@b28-cia-12-1151] Others have shown that physical inactivity, body fat, diabetes, depression, sleeping disturbances, number of medications and falls were identified as factors associated with grip strength in community-dwelling elderly patients,[@b29-cia-12-1151] although a Spanish study suggests that the grip strength poorly discriminates prefrail from frail individuals.[@b30-cia-12-1151] It reveals a linear age-dependent decline in very old men (aged ≥85) and a curvilinear decline in very old women; in both sexes, better values were observed in subjects with higher baseline physical activity, height, fat-free mass, better self-rated health and not having arthritis of the hand(s).[@b31-cia-12-1151] In our group of geriatric inpatients, grip strength correlated with anthropometric, clinical and functional measures ([Table 3](#t3-cia-12-1151){ref-type="table"}). However, it is difficult to determine the cause-and-effect dependence between muscle strength and other functional measures. In the Spearman's rank correlation analysis, grip strength correlated positively with IADL, MMSE and Barthel Index and negatively with GDS and VAS. Grip strength appears to influence both physical and mental functioning, between which there exists a bidirectional relationship. As expected, grip strength rose with higher body growth and mass. Similar to Joosten et al,[@b32-cia-12-1151] we did not observe a significant association between anemia and low grip strength. However, correlations with hemoglobin concentration and RBC count suggest possible treatment for improving the muscle strength and, therefore, susceptibility to frailty. Sex had the strongest influence on grip strength in a multivariate linear regression analysis. Grip strength was higher in men than in women (23.1±9.8 versus 14.7±7.4 kg; *P*\<0.001) in a sample of 209 geriatric inpatients examined by Joosten et al.[@b32-cia-12-1151] We observed that the CRP concentration was an independent negative determinant of grip strength in our sample of patients, which confirms the deleterious impact of inflammation on muscle function. A meta-analysis by Soysal et al revealed that frailty and prefrailty were associated with higher inflammatory parameters, although higher serum CRP and interleukin-6 (IL-6) levels were not associated with frailty in three longitudinal studies.[@b33-cia-12-1151] However, IL-6 and CRP levels were inversely associated with physical and cognitive performance as well as survival in a large cohort of community-dwelling older individuals.[@b34-cia-12-1151] Prior myocardial infarction was another independent factor associated negatively with grip strength in our patients. This factor was found to be a determinant of lower physical function in 51 community-dwelling patients aged 65+ years with established chronic coronary heart disease.[@b35-cia-12-1151] Many other clinical conditions, including diabetes[@b36-cia-12-1151] and anorexia,[@b37-cia-12-1151] may drive sarcopenia and decrease in muscle strength, increasing the risk of frailty. Treatment with the use of antidepressants also revealed a negative association with muscle strength ([Tables 1](#t1-cia-12-1151){ref-type="table"} and [4](#t4-cia-12-1151){ref-type="table"}). Depression and the presence of comorbidities that interact with depressive symptomatology increase the risk of incident frailty.[@b38-cia-12-1151] Depression combined with inappropriate nutrition predisposes to muscle strength decrease.[@b39-cia-12-1151] Lakey et al demonstrated an association between antidepressant treatment (regardless of depression status) and increased incidence of frailty in older women.[@b40-cia-12-1151] It is unclear whether all antidepressant classes carry a similar relationship with frailty. Therefore, further research is needed to explain the possible role of antidepressants in the depression--frailty relationship. In contrast to other studies,[@b41-cia-12-1151]--[@b44-cia-12-1151] in our observation, statin use was positively associated with muscle strength ([Tables 1](#t1-cia-12-1151){ref-type="table"} and [4](#t4-cia-12-1151){ref-type="table"}). This finding needs confirmation in further studies. We assume, that a beneficial impact of statins on the cardiovascular system, and therefore, their positive effect on organ perfusion may outweigh their direct deleterious effect on skeletal muscles in some patients. However, Rengo et al found that chronic statin therapy in healthy asymptomatic individuals does not promote deleterious myofilament structural or functional adaptations.[@b45-cia-12-1151] Our observation of the association between grip strength and MMSE scores ([Tables 1](#t1-cia-12-1151){ref-type="table"} and [3](#t3-cia-12-1151){ref-type="table"}), as well as the GDS ([Table 3](#t3-cia-12-1151){ref-type="table"}), support the concept of a psychologic dimension of physical frailty in geriatric inpatients. The prognostic value of an assessment that accounts for both physical and mental components of frailty is superior to the separate values of these components.[@b46-cia-12-1151] Grip strength was not predictive of survival prognosis in our group; low physical activity was the only frailty component associated with 2-year mortality. In another study performed in geriatric inpatients in Poland, that did not include frailty assessment, 5.5-year mortality was associated with age, cognitive function, IADL score, Charlson comorbidity index, body mass index, cholesterol and hemoglobin levels.[@b47-cia-12-1151] Despite the limitations of our study, especially a relatively low number of participants and short follow-up period, this analysis confirmed that grip strength is influenced by multiple factors of patient health status. Frailty emerged as one of the top predictors of adverse health outcomes, disability and mortality in older patients with multiple chronic conditions,[@b48-cia-12-1151],[@b49-cia-12-1151] including patients with COPD,[@b50-cia-12-1151] diabetes,[@b51-cia-12-1151] cancer,[@b52-cia-12-1151] liver cirrhosis,[@b53-cia-12-1151] end-stage renal disease,[@b54-cia-12-1151] heart failure[@b55-cia-12-1151] and patients who underwent transcatheter aortic valve implantation.[@b14-cia-12-1151] Although not included in all frailty models, grip strength constitutes a valuable diagnostic component of this clinical syndrome.

Conclusion
==========

Cognitive function, somatic comorbidity and medical treatment affect grip strength as a measure of physical frailty in geriatric inpatients. Grip strength was not predictive of 2-year mortality in this group.
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###### 

Standardized coefficients for measures associated with grip strength in geriatric inpatients in the multivariate linear regression model (corrected *R*^2^=0.686), N=80

  Measure                         β coefficient ± SD   β coefficient 95% confidence interval   Partial correlation   Semipartial correlation   *P*-value
  ------------------------------- -------------------- --------------------------------------- --------------------- ------------------------- -----------
  Mini-Mental State Examination   0.239±0.067          0.106--0.373                            0.388                 0.227                     0.001
  Statin treatment                0.213±0.065          0.083--0.343                            0.359                 0.207                     0.002
  Antidepressant treatment        −0.163±0.067         −0.296 to −0.029                        −0.275                −0.154                    0.018
  Prior myocardial infarction     −0.190±0.067         −0.323 to −0.057                        −0.319                −0.181                    0.006
  C-reactive protein              −0.253±0.067         −0.388 to −0.119                        −0.406                −0.239                    \<0.001
  Female sex                      −0.671±0.065         −0.800 to −0.542                        −0.773                −0.656                    \<0.001

**Abbreviation:** SD, standard deviation.

###### 

Clinical and functional characteristics of geriatric inpatients with frailty (FR) as compared to inpatients without frailty (NF)

  -----------------------------------------------------------------------------------------------------------------
  Variable                                        Whole group (N=80)\   FR (n=32)\    NF (n=48)\    FR versus NF\
                                                  Mean ± SD             Mean ± SD     Mean ± SD     *P*-value
  ----------------------------------------------- --------------------- ------------- ------------- ---------------
  Age, years                                      78.6±7.0              80.0±6.9      77.7±7.0      0.164

  Sex, percentage of females                      68.8                  71.9          66.7          0.625

  Number of medications used                      6.71±3.30             7.75±3.37     6.02±3.09     0.037

  Body mass, kg                                   71.4±14.0             70.6±14.8     71.8±13.6     0.773

  Growth, m                                       1.59±0.09             1.59±0.08     1.60±0.09     0.926

  Body mass index, kg/m^2^                        27.8±4.8              27.6±4.8      28.0±4.9      0.903

  Waist, cm                                       98.3±12.8             99.9±13.9     97.3±12.1     0.467

  Waist--hip ratio                                0.9±0.1               0.9±0.1       0.9±0.1       0.449

  Systolic blood pressure, mmHg                   132.6±18.5            134.1±19.2    131.7±18.1    0.547

  Diastolic blood pressure, mmHg                  76.5±10.2             76.87±11.34   76.25±9.54    0.849

  Mini-Mental State Examination score             25.5±4.1              24.3±4.0      26.3±4.0      0.014

  Geriatric Depression Scale                      5.6±2.5               6.7±2.7       4.8±2.1       0.002

  Barthel Index                                   79.9±19.0             68.9±20.4     87.3±14.0     \<0.001

  Instrumental Activities of Daily Living scale   19.7±5.9              16.4±5.6      21.8±5.1      \<0.001

  Modified timed up and go test, points           5.6±2.3               4.7±1.9       6.2±2.3       0.004

  Visual Analog Scale, points                     3.8±3.1               4.4±3.4       3.4±3.0       0.280

  Red blood cells, T/L                            4.3±0.6               4.1±0.8       4.4±0.5       0.036

  Hemoglobin, g/dL                                13.0±1.8              12.5±2.1      13.4±1.5      0.027

  Hematocrit, %                                   38.3±4.9              36.9±5.8      39.2±3.9      0.100

  Lymphocytes, G/L                                1.7±0.7               1.4±0.4       1.8±0.8       0.006

  C-reactive protein, mg/L                        6.9±7.3               8.9±11.1      5.5±1.7       0.350

  Albumin, g/L                                    39.1±4.8              37.8±5.6      39.9±4.0      0.036

  Vitamin B12, pmol/L                             378.1±261.3           415.0±374.1   352.9±140.9   0.770

  Vitamin D, ng/mL                                14.9±8.7              13.1±9.8      16.2±7.6      0.025

  Total cholesterol, mg/dL                        183.6±47.7            168.9±38.3    193.3±51.1    0.036

  HDL-cholesterol, mg/dL                          58.1±18.7             51.9±17.9     62.2±18.2     0.004

  LDL-cholesterol, mg/dL                          104.0±42.6            92.6±32.3     111.6±47.1    0.162

  Triglycerides, mg/dL                            100.8±35.6            105.7±36.9    97.5±34.7     0.270

  Bilirubin, mg/dL                                0.59±0.32             0.58±0.33     0.59±0.31     0.685

  Sodium, mmol/L                                  140.7±3.4             140.1±3.3     141.1±3.5     0.062

  Insulin, µIU/mL                                 12.4±12.3             14.1±7.5      11.2±7.1      0.988

  Cortisol, ng/mL                                 166.8±230.9           141.3±59.8    183.9±294.1   0.420
  -----------------------------------------------------------------------------------------------------------------

**Abbreviations:** HDL, high-density lipoprotein; LDL, low-density lipoprotein; SD, standard deviation

###### 

Correlation between clinical, functional or laboratory measures and grip strength in geriatric inpatients (N=80)

  Measure correlated with grip strength           Spearman *R*   *P*-value
  ----------------------------------------------- -------------- -----------
  Instrumental Activities of Daily Living scale   0.400          \<0.001
  Growth                                          0.381          \<0.001
  Mini-Mental State Examination score             0.380          \<0.001
  Barthel Index of activities of daily living     0.376          \<0.001
  Hemoglobin concentration                        0.293          0.008
  Body mass                                       0.282          0.011
  Hematocrit                                      0.275          0.013
  Lymphocyte count                                0.268          0.015
  Red blood cell count                            0.264          0.018
  Sodium concentration                            0.263          0.018
  Bilirubin concentration                         0.232          0.038
  Number of medications used                      −0.332         0.002
  Visual Analog Scale score                       −0.371         \<0.001
  C-reactive protein concentration                −0.383         \<0.001
  Geriatric Depression Scale                      −0.480         \<0.001

###### 

Comparison of GS between groups of geriatric inpatients with different demographic, clinical and functional characteristics with and without adjustment for sex

  Characteristic                                                            Patients with the characteristic   Patients without the characteristic   *P*-value
  ------------------------------------------------------------------------- ---------------------------------- ------------------------------------- -----------
  Two-year survival                                                         19.9±9.7 (70)                      18.2±5.4 (10)                         0.438
  Two-year survival[\*](#tfn3-cia-12-1151){ref-type="table-fn"}             15.8±5.7 (70)                      16.2±4.8 (10)                         0.754
  Sex (males versus females)                                                28.3±10.1 (25)                     15.8±5.5 (55)                         \<0.001
  Statin treatment                                                          22.3±10.7 (37)                     17.4±7.1 (43)                         0.055
  Statin treatment[\*](#tfn3-cia-12-1151){ref-type="table-fn"}              17.5±6.0 (37)                      14.4±4.7 (43)                         0.002
  Prior myocardial infarction                                               15.2±5.8 (12)                      20.5±9.5 (68)                         0.097
  Prior myocardial infarction[\*](#tfn3-cia-12-1151){ref-type="table-fn"}   11.7±4.3 (12)                      16.4±5.4 (68)                         0.007
  Depression                                                                17.2±8.3 (25)                      20.8±9.5 (55)                         0.069
  Depression[\*](#tfn3-cia-12-1151){ref-type="table-fn"}                    14.1±4.5                           16.7±5.8                              0.085
  Antidepressant treatment                                                  13.3±3.8 (11)                      20.7±9.5 (69)                         0.006
  Antidepressant treatment[\*](#tfn3-cia-12-1151){ref-type="table-fn"}      11.5±3.4 (11)                      16.6±5.5 (69)                         0.004

**Note:**

GS adjusted for sex: GS values in males were multiplied by a value 1 minus SP^2^, where SP denotes a semipartial coefficient for female sex in the multivariate linear regression analysis ([Table 1](#t1-cia-12-1151){ref-type="table"}).

**Abbreviations:** GS, grip strength; SD, standard deviation.
